First-in-Human Evaluation of


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
12 2022
Historique:
received: 10 01 2022
revised: 31 03 2022
pubmed: 1 7 2022
medline: 6 12 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

Phosphodiesterase-4 (PDE4), which metabolizes the second messenger cyclic adenosine monophosphate (cAMP), has 4 isozymes: PDE4A, PDE4B, PDE4C, and PDE4D. PDE4B and PDE4D have the highest expression in the brain and may play a role in the pathophysiology and treatment of depression and dementia. This study evaluated the properties of the newly developed PDE4B-selective radioligand

Identifiants

pubmed: 35772961
pii: jnumed.122.263838
doi: 10.2967/jnumed.122.263838
pmc: PMC9730922
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily G, Member 2 0
Cyclic Nucleotide Phosphodiesterases, Type 4 EC 3.1.4.17
Neoplasm Proteins 0
Radiopharmaceuticals 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1919-1924

Subventions

Organisme : Intramural NIH HHS
ID : ZIA MH002852
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002793
Pays : United States

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Hum Brain Mapp. 2003 Aug;19(4):224-47
pubmed: 12874777
Neuroimage. 2008 Jul 1;41(3):690-8
pubmed: 18456516
Nucl Med Biol. 2008 May;35(4):493-500
pubmed: 18482687
Mol Psychiatry. 2002;7 Suppl 1:S29-34
pubmed: 11986993
Synapse. 2010 Feb;64(2):172-6
pubmed: 19852069
J Nucl Med. 2009 May;50(5):749-56
pubmed: 19372471
J Nucl Med. 2006 Mar;47(3):520-7
pubmed: 16513622
Nat Rev Drug Discov. 2006 Aug;5(8):660-70
pubmed: 16883304
Nucl Med Biol. 2000 Oct;27(7):657-60
pubmed: 11091108
ACS Chem Neurosci. 2020 May 6;11(9):1311-1323
pubmed: 32212718
J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
pubmed: 17519979
J Med Chem. 2017 Oct 26;60(20):8538-8551
pubmed: 28957634
Expert Opin Ther Targets. 2013 Sep;17(9):1011-27
pubmed: 23883342
Sci Rep. 2017 Jan 05;7:40115
pubmed: 28054669
Mol Psychiatry. 2017 May;22(5):754-759
pubmed: 27725657
Nat Med. 2021 May;27(5):862-870
pubmed: 33927413
Biochem J. 1998 Jul 1;333 ( Pt 1):139-49
pubmed: 9639573
NeuroRx. 2005 Jan;2(1):86-98
pubmed: 15717060

Auteurs

Yuichi Wakabayashi (Y)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Per Stenkrona (P)

Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.

Ryosuke Arakawa (R)

Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.

Xuefeng Yan (X)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Maia G Van Buskirk (MG)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Madeline D Jenkins (MD)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Jose A Montero Santamaria (JAM)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Kevin P Maresca (KP)

Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.

Akihiro Takano (A)

Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.

Jeih-San Liow (JS)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Thomas A Chappie (TA)

Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.

Andrea Varrone (A)

Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.

Sangram Nag (S)

Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.

Lei Zhang (L)

Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.

Zoë A Hughes (ZA)

Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.

Christopher J Schmidt (CJ)

Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.

Shawn D Doran (SD)

Worldwide Research, Development, and Medicine, Pfizer Inc., New York, New York; and.

Andrew Mannes (A)

Anesthesia Department, NIH Clinical Center, Bethesda, Maryland.

Paolo Zanotti-Fregonara (P)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Maarten Ooms (M)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Cheryl L Morse (CL)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Sami S Zoghbi (SS)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Christer Halldin (C)

Department of Clinical Neuroscience Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.

Victor W Pike (VW)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland.

Robert B Innis (RB)

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland; robert.innis@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH